← Every insider
Cheryl Cohen
Director. Files against IBRX. Everything below is filed with the SEC within two business days of the trade. Filed as Cohen Cheryl.
Filed lines
6
2026-07-02 to 2026-10-02
Bought
—
open market
Sold
$2.1M
open market
Net
$2.1M
sold more
Every reported line
Purchases, sales, grants, option exercises and shares withheld for tax.
| Company | Action | Value |
|---|---|---|
| IBRXImmunitybio Inc2026-10-02 | Option exercise10b5-1 plan | $166.8K |
| IBRXImmunitybio Inc2026-10-02 | Sale10b5-1 plan | $851.1K |
| IBRXImmunitybio Inc2026-10-02 | Option exercisederivative10b5-1 plan | — |
| IBRXImmunitybio Inc2026-07-02 | Option exercise10b5-1 plan | $166.8K |
| IBRXImmunitybio Inc2026-07-02 | Sale10b5-1 plan | $1.2M |
| IBRXImmunitybio Inc2026-07-02 | Option exercisederivative10b5-1 plan | — |
Source: SEC Form 4 and Form 144 filings, via EDGAR. Form 144 carries no filer identifier, so those notices are matched to this page by name alone. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
Follow Cheryl Cohen by email
Cheryl Cohen's new Form 4 trades, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.